The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...

With U.S. headquarters in Plainsboro, Novo Nordisk told NJBIZ, "NAION is a very rare eye disease, and it is not an adverse ...

For the multi-dose pen, Eli Lilly submitted a bioequivalence (BE) study conducted in the United States. However, the SEC noted that the study comparing a multi-dose pen with a preservative to the ...

For a drug that has been on the market for only a year, Eli Lilly and Co.’s anti ... and diabetes treatment Trulicity ($7.4 billion). Lilly diebetes drug Mounjaro, which uses the same active ...

In this article, we are going to take a look at where Eli ... drugs Trulicity, Verzenio and Taltz. The company operates in a single business segment: human pharmaceutical products. Eli Lilly ...

We recently compiled a list of the 10 Dividend Knights that Beat The Market Last 3 Years. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the ...

Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products. Lilly said Thursday it will expand a ...

Seven months after pharmaceutical giant Eli Lilly and Company made its entrance into southeast Wisconsin by acquiring a facility in Pleasant Prairie built by Nexus Pharmaceuticals, the company ...